Clear Street Markets LLC Abb Vie Inc. Transaction History

Clear Street Markets LLC

$379 Million
Q3 2024

A detailed history of Clear Street Markets LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 200 shares of ABBV stock, worth $35,602. This represents 0.01% of its overall portfolio holdings.

Number of Shares

200

Previous 800 75.0%

Holding current value

$35,602

Previous $137,000 71.53%

% of portfolio

0.01%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $98,304 - $119,598	-600 Reduced 75.0%	200 $39,000
Q2 2024 Jul 26, 2024	SELL	$154.79 - $180.76 $6.22 Million - $7.27 Million	-40,200 Reduced 98.05%	800 $137,000
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $887,001 - $1.01 Million	5,550 Added 15.66%	41,000 $7.47 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $681,120 - $767,101	4,950 Added 16.23%	35,450 $5.49 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $748,771 - $866,813	-5,605 Reduced 15.52%	30,500 $4.55 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $97,527 - $121,366	736 Added 2.08%	36,105 $4.86 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $729,991 - $840,693	-5,048 Reduced 12.49%	35,369 $5.64 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $1.81 Million - $2.17 Million	-13,064 Reduced 24.43%	40,417 $6.53 Million
Q3 2022 Nov 02, 2022	BUY	$134.21 - $153.93 $3.51 Million - $4.03 Million	26,188 Added 95.95%	53,481 $7.18 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $968,019 - $1.23 Million	-7,034 Reduced 20.49%	27,293 $4.18 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $9.21 Million - $11.4 Million	-69,791 Reduced 67.03%	34,327 $5.57 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $7.91 Million - $10 Million	73,618 Added 241.37%	104,118 $14.1 Million
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $1.91 Million - $2.17 Million	-17,996 Reduced 37.11%	30,500 $3.29 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $2.71 Million - $3.02 Million	25,745 Added 113.16%	48,496 $5.46 Million
Q1 2021 Apr 14, 2021	SELL	$102.3 - $112.62 $4.14 Million - $4.56 Million	-40,502 Reduced 64.03%	22,751 $2.46 Million
Q4 2020 Feb 25, 2021	SELL	$80.49 - $108.67 $95,944 - $129,534	-1,192 Reduced 1.85%	63,253 $6.78 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $4.1 Million - $4.82 Million	47,772 Added 286.52%	64,445 $5.65 Million
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $301,624 - $403,617	-4,111 Reduced 19.78%	16,673 $1.64 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $6.58 Million - $9.98 Million	-102,073 Reduced 83.08%	20,784 $1.58 Million
Q4 2019 Jan 13, 2020	BUY	$72.13 - $90.25 $7.87 Million - $9.85 Million	109,157 Added 796.77%	122,857 $10.9 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $459,754 - $552,756	7,300 Added 114.06%	13,700 $1.04 Million
Q2 2019 Jul 16, 2019	SELL	$65.7 - $83.98 $321,930 - $411,502	-4,900 Reduced 43.36%	6,400 $465,000
Q1 2019 May 09, 2019	SELL	$77.14 - $90.79 $161,994 - $190,659	-2,100 Reduced 15.67%	11,300 $911,000
Q4 2018 Jan 23, 2019	SELL	$77.85 - $96.01 $124,559 - $153,616	-1,600 Reduced 10.67%	13,400 $1.24 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $577,915 - $642,460	6,500 Added 76.47%	15,000 $1.42 Million
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $556,636 - $658,626	6,200 Added 269.57%	8,500 $788,000
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $3 Million - $4.02 Million	-32,600 Reduced 93.41%	2,300 $218,000
Q4 2017 Feb 01, 2018	BUY	$89.56 - $98.21 $2.5 Million - $2.74 Million	27,900 Added 398.57%	34,900 $3.38 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $488,949 - $624,540	7,000	7,000 $622,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.

Account

Clear Street Markets LLC Abb Vie Inc. Transaction History